Coloplast CEO looks forward to pivotal launch

The medtech company Coloplast has a number of important studies in the pipeline, and the its President and CEO Kristian Villumsen calls the launch of a new catheter platform absolutely crucial for the company's future continence operations.

CEO at Coloplast Kristian Villumsen looks forward to trial with antibacterial catheter platform. | Photo: Coloplast / PR

Coloplast is launching several clinical trials around the New Year in both in the UK and Germany, including important studies testing a new digital ostomy solution that can warn users of leaks via a sensor, an implanted nerve stimulator against overactive bladder disorder and a new antibacterial catheter platform, as reported by Danish business daily Børsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs